Compounds > gefitinib
Page last updated: 2024-09-03

gefitinib and Chylopericardium

gefitinib has been researched along with Chylopericardium in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, J; Guo, R; Wang, X; Yao, J1
Haraguchi, N; Kikuchi, N; Kodama, T; Satoh, H; Sekizawa, K1

Other Studies

2 other study(ies) available for gefitinib and Chylopericardium

ArticleYear
[Clinical Observation of Gefitinib with Pericardial Perfusion for 
Advanced Non-small Cell Lung Cancer].
    Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2018, Jan-20, Volume: 21, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; ErbB Receptors; Female; Gefitinib; Humans; Lung Neoplasms; Male; Middle Aged; Perfusion; Pericardial Effusion; Pericardium; Quinazolines; Retrospective Studies; Treatment Outcome

2018
Response to gefitinib in pericardial effusion due to lung cancer.
    Acta medica (Hradec Kralove), 2003, Volume: 46, Issue:4

    Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Epidermal Growth Factor; Female; Gefitinib; Humans; Lung Neoplasms; Pericardial Effusion; Protein-Tyrosine Kinases; Quinazolines

2003